According to FDA statement, Becton Dickinson (BDX) is “recalling one lot of ChloraPrep Clear 1 mL applicators due to fungal contamination under certain environmental conditions allowing the growth of Aspergillus penicillioides. The Aspergillus penicillioides within the packaging can contaminate the surface of the applicator and/or gloved hands of the health care professional and then consequently the sterile field. Since the applicator is used for site preparation prior to an invasive procedure, a contaminated applicator can result in direct inoculation of the fungus into tissues. This lot was distributed globally beginning in September 2023.”
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDX:
- Becton Dickinson’s Hold Rating: Balancing Strong Financials with Strategic Uncertainty
- Becton Dickinson price target raised to $279 from $278 at Barclays
- Becton Dickinson director buys $350.4K in common stock
- Becton Dickinson: Undervalued Growth Opportunity with Strategic Options for Shareholder Value Enhancement
- Becton, Dickinson’s Strong Q1 Amidst Global Challenges